 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H17N3O2 |
| Molar mass | 307.353 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Anitrazifen is a drug displaying COX-2 inhibitor activity.[1]
References[edit]
- ^ Cullen E (May 1984). "Novel anti-inflammatory agents". Journal of Pharmaceutical Sciences. 73 (5): 579–89. doi:10.1002/jps.2600730503. PMID 6429314.
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
